Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 7
2011 6
2012 2
2013 5
2014 6
2015 18
2016 11
2017 16
2018 16
2019 29
2020 37
2021 33
2022 38
2023 37
2024 24
2025 32
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
ctDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial.
Manca P, Paoli M, Galardi F, Morano F, Di Donato S, Biganzoli L, Malorni L, Nardone A, Ambrosini M, Sciortino C, Oldani S, Ghelardi F, Nasca V, Damonte C, Villa C, Fazio R, Mohamed S, Demichelis F, Montroni I, Pusceddu S, Cremolini C, Lonardi S, Benelli M, Pietrantonio F. Manca P, et al. Among authors: cremolini c. Clin Cancer Res. 2026 Mar 2;32(5):905-915. doi: 10.1158/1078-0432.CCR-25-2773. Clin Cancer Res. 2026. PMID: 41427962 Clinical Trial.
Upfront Modified FOLFOXIRI Plus Panitumumab for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Results of the Phase III TRIPLETE Study.
Conca V, Rossini D, Antoniotti C, Lonardi S, Pietrantonio F, Moretto R, Antonuzzo L, Randon G, Lavacchi D, Pozzo C, Marmorino F, Bergamo F, Tamburini E, Passardi A, Fazio R, Murgioni S, Borelli B, Buonadonna A, Germani MM, Formica V, Carullo M, Bordonaro R, Aprile G, Zaniboni A, Masi G, Boni L, Cremolini C. Conca V, et al. Among authors: cremolini c. J Clin Oncol. 2026 Feb 10;44(5):361-369. doi: 10.1200/JCO-25-01337. Epub 2026 Jan 8. J Clin Oncol. 2026. PMID: 41505697 Free PMC article. Clinical Trial.
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis.
Strickler JH, Cercek A, Siena S, André T, Ng K, Van Cutsem E, Wu C, Paulson AS, Hubbard JM, Coveler AL, Fountzilas C, Kardosh A, Kasi PM, Lenz HJ, Ciombor K, Elez E, Bajor DL, Cremolini C, Sanchez F, Nayeri M, Feng W, Bieda M, Bekaii-Saab TS. Strickler JH, et al. Among authors: cremolini c. Nat Commun. 2026 Jan 12;17(1):1068. doi: 10.1038/s41467-025-67824-z. Nat Commun. 2026. PMID: 41526345 Free PMC article. Clinical Trial.
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial.
Botticelli A, Cremolini C, Scagnoli S, Biffoni M, Lonardi S, Fornaro L, Guarneri V, De Giorgi U, Ascierto PA, Blandino G, D'Amati G, Aglietta M, Conte P, Crimini E, Ceracchi M, Pisegna S, Verkhovskaia S, Bordonaro R, Bracarda S, Butturini G, Del Mastro L, DeCensi A, Fabbri A, Fenocchio E, Gori S, Metro G, Pessino A, Pozzessere D, Puglisi F, Tamberi S, Zambelli A, Marino D, Capoluongo E, Cappuzzo F, Cerbelli B, Giannini G, Malapelle U, Mazzuca F, Nuti M, Pruneri G, Simmaco M, Strigari L, Tonini G, Martini N, Curigliano G, Marchetti P. Botticelli A, et al. Among authors: cremolini c. Clin Cancer Res. 2026 Jan 6;32(1):45-55. doi: 10.1158/1078-0432.CCR-25-0430. Clin Cancer Res. 2026. PMID: 40833744 Free PMC article. Clinical Trial.
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group.
Gandini A, Probst V, Landi M, De Grandis MC, Cremolini C, Lonardi S, Girot P, Decraecker M, Passardi A, Salvatore L, Pastorino A, Jones JC, Grados L, Sayah L, Trouilloud I, Tougeron D, Taieb J. Gandini A, et al. Among authors: cremolini c. Clin Res Hepatol Gastroenterol. 2026 Jan;50(1):102746. doi: 10.1016/j.clinre.2025.102746. Epub 2025 Dec 16. Clin Res Hepatol Gastroenterol. 2026. PMID: 41412477 Free article.
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.
Stahler A, Modest DP, Stintzing S, Borelli B, Keller T, Held S, Fischer von Weikersthal L, Müller L, Graeven U, Decker T, Heintges T, Kahl C, Hoppe B, Kiani A, Kaiser F, Schwaner I, Fruehauf S, Karthaus M, Trarbach T, Klauschen F, Horst D, Cremolini C, Heinemann V. Stahler A, et al. Among authors: cremolini c. J Clin Oncol. 2026 Jan;44(1):31-41. doi: 10.1200/JCO-25-00596. Epub 2025 Nov 18. J Clin Oncol. 2026. PMID: 41252656
Surrogate markers of intestinal dysfunction associated with survival in advanced cancers.
Birebent R, Drubay D, Alves Costa Silva C, Marmorino F, Vitali G, Piccinno G, Hurtado Y, Bonato A, Belluomini L, Messaoudene M, Routy B, Fidelle M, Zalcman G, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, Scherpereel A, Pegliasco H, Ghiringhelli F, Reni A, Barlesi F, Albiges L, Planchard D, Martinez S, Besse B, Segata N, Cremolini C, Zitvogel L, Iebba V, Derosa L. Birebent R, et al. Among authors: cremolini c. Oncoimmunology. 2025 Dec;14(1):2484880. doi: 10.1080/2162402X.2025.2484880. Epub 2025 Apr 6. Oncoimmunology. 2025. PMID: 40189749 Free PMC article.
Attenuation-based estimation of myocardial extracellular volume from ECG-ungated whole-body CT examinations as an early biomarker of chemotherapy-induced cardiotoxicity: preliminary findings.
Aquaro GD, Faggioni L, Francischello R, Guidi S, Del Giudice ML, Salani F, Lencioni R, Galimberti S, Masi G, Cremolini C, Neri E, Cioni D. Aquaro GD, et al. Among authors: cremolini c. Radiol Med. 2025 Nov 18. doi: 10.1007/s11547-025-02148-y. Online ahead of print. Radiol Med. 2025. PMID: 41252121
289 results